Docusate (Docusate)


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 86.6%
Ill-defined Disorder 6.7%
Diarrhoea 3.4%
Psychotic Disorder 1.7%
Depression 0.8%
Multiple Myeloma 0.8%
Toxicity To Various Agents 26.7%
Death 13.3%
Vertebral Artery Occlusion 13.3%
Brain Stem Stroke 6.7%
Cardioactive Drug Level Increased 6.7%
Cerebrovascular Accident 6.7%
Fatigue 6.7%
Respiratory Arrest 6.7%
Respiratory Distress 6.7%
Weight Increased 6.7%
Concomitant
Multiple Myeloma 26.1%
Product Used For Unknown Indication 12.6%
Acute Lymphocytic Leukaemia 7.1%
Acute Myeloid Leukaemia 5.1%
Plasma Cell Myeloma 5.1%
Multiple Sclerosis 4.7%
Stem Cell Transplant 4.3%
Convulsion 3.6%
Myelodysplastic Syndrome 3.6%
Gastric Cancer 3.2%
Hormone Replacement Therapy 3.2%
Sarcoma Metastatic 3.2%
Schizophrenia 3.2%
Ill-defined Disorder 2.4%
Pancreatic Carcinoma 2.4%
Prophylaxis Of Nausea And Vomiting 2.4%
Anaplastic Large Cell Lymphoma T- And Null-cell Types 2.0%
Breast Cancer 2.0%
Hypertension 2.0%
Osteoporosis 2.0%
White Blood Cell Count Decreased 14.7%
Vomiting 13.7%
Thrombocytopenia 6.3%
Vision Blurred 6.3%
Pneumonia 5.3%
Syncope 5.3%
Platelet Count Decreased 4.2%
Urinary Tract Infection 4.2%
Weight Decreased 4.2%
Weight Increased 4.2%
White Blood Cell Count Increased 4.2%
Depression 3.2%
International Normalised Ratio Increased 3.2%
Neutropenia 3.2%
Off Label Use 3.2%
Peripheral Sensory Neuropathy 3.2%
Rash Pruritic 3.2%
Respiratory Failure 3.2%
Sepsis 3.2%
Aphagia 2.1%

Drug Data